Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
PHASE1
This phase IB trial studies the feasibility of using a functional laborator...
A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia
PHASE2
Adult acute lymphoblastic leukemia (ALL) includes Ph-positive (Phpos) ALL, ...
Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)
N/A
This is a multicentre ambispective cohort study involving French patients w...
Status
Completed
Location
CHU SUD Reunion GHSR
Start Date
2018-02-23
Trial ID
NCT04048564
A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)
PHASE1
The purpose of this research study is to see if a drug called LP-118 is saf...